Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Ampyra (dalfampridine)
Biogen Idec receives notification of PDUFA date extension for PLEGRIDY™ (peginterferon beta-1a)
Allelic combinations of immune-response genes associated with glatiramer acetate treatment response in Russian multiple sclerosis patients.
Effects of a 4-month Ananda Yoga Program on Physical and Mental Health Outcomes for Persons With Multiple Sclerosis.
A Unified Frequency Domain Model to Study the Effect of Demyelination on Axonal Conduction.
Modulation of immune function occurs within hours of therapy initiation for multiple sclerosis.
In vivo time-lapse imaging shows dynamic oligodendrocyte progenitor behavior during zebrafish development.
Epigenetic Modulation of Human Induced Pluripotent Stem Cell Differentiation to Oligodendrocytes.
Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients.
Biologics-induced autoimmune diseases.
Combination therapy of interferon Beta-1b and tacrolimus: a pilot safety study.
Progressive Multifocal Leukoencephalopathy: Why Gray and White Matter.
A randomized controlled phase II trial of riluzole in early multiple sclerosis.
The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis.
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.
Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results.
How many injections did you miss last month? A simple question to predict interferon β-1a adherence in multiple sclerosis.
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
SigmaPharm Laboratories Products
[The effect of flupirtine, various analgesics and muscle relaxants on skeletal muscle tone in the conscious rat].
Biomarkers for Brain Disorders: Challenges and Opportunities
NF-κB transcriptional activation by TNFα requires phospholipase C, extracellular signal-regulated kinase 2 and poly(ADP-ribose) polymerase-1.
Multiple sclerosis: A lifestyle disease?
Multifocal Tumefactive Demyelination Mimicking Intracranial Neoplasm.
Clinical and MRI predictors of response to interferon-beta and glatiramer acetate in relapsing-remitting multiple sclerosis patients.

Pages